The pharmaceutical sector of Hong Kong stocks strengthened, and innovative pharmaceuticals and CXO leaders collectively boosted. As of press release, Medicinal Biotech and Medicinal Kangde have risen 9%, BeiGene Shenzhou has risen by about 8%, and Kangfang Biotech has risen by about 6%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.